Last reviewed · How we verify

NCT06555900: PREDICT-CE

Predicting Episodes of Intracranial Hypertension in Neuro-injured Patients: Development of a Decision Algorithm Using Artificial Intelligence (PREDICT-CE)

Recruiting now Last updated 15 August 2024
What this trial tests

trial in Creation of a Warehouse of Clinical Data and Physiological Signals at the Patient's Bedside in 500 participants. Currently enrolling.

Timeline
17 December 2020
Primary endpoint
30 June 2025
30 June 2025

Quick facts

Lead sponsorUniversity Hospital, Brest
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment500
Start date17 December 2020
Primary completion30 June 2025
Estimated completion30 June 2025
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Brest

Who can join

Adults 18 to 99, any sex, with Creation of a Warehouse of Clinical Data and Physiological Signals at the Patient's Bedside. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators wish to build up a database of clinical data and physiological signals with a view to developing a predictive algorithm based on continuous analysis of the intracranial pressure waveform and other parameters commonly used in intensive care to predict the occurrence of an episode of intracranial hypertension (HTIC). This algorithm will be designed using supervised learning statistical methods based on innovative statistical analysis methods (artificial intelligence). These methods are classically used to exploit massive data such as sensor data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Brest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06555900.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing